2 Days
المصدر:
المشهد
المصدر: المشهد
2 Daysالمشهد
المصدر: المشهد
2 Daysجاهز للتشغيل
جاهز للتشغيل
News reports circulated that Trump is receiving secret treatment for obesity using the drug "Rettrutide," despite the fact that the U.S. Food and Drug Administration has not yet approved it. This topic sparked widespread controversy regarding the possibility of obtaining experimental medications prior to official approvals, especially since the law allows for such access in exceptional cases through the "Expanded Access" pathway. An official statement denied any connection between Trump and the drug. However, the incident revealed how certain figures can access new medications before they are publicly available, amidst an unregulated market profiting from the demand for drugs before final approval. "Rettrutide" is considered a promising future medication for treating obesity, as it activates three hormonal mechanisms, leading to significant weight loss results.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading